Clinical trial NCT06589843: Artificial Intelligent Image Processing and Diagnosis of Pulmonary Vessels in CT
Official title: Artificial Intelligent Image Processing and Diagnosis of Pulmonary Vessels in CT
Study type: OBSERVATIONAL
Overall status: NOT_YET_RECRUITING
Conditions: Radiology
Vascular Diseases
Lead sponsor: Chinese PLA General Hospital
Sponsor class: OTHER
First posted: 2024-09-19
Enrollment: 15000
Sex: ALL
Minimum age (years): 18
Maximum age (years): 100
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: CASE_ONLY
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients with chest pain, lung cancer, pulmonary embolism, and routine inpatient physical examination were studied

Brief summary: In this study, patients with chest pain, lung cancer, pulmonary embolism, and routine inpatient physical examination were selected as the research objects, and the experimental design of retrospective cohort study was adopted to carry out artificial intelligence analysis related to pulmonary vascular diseases in patients with multi-dimensional big data. The multi-modal CT acquisition process included plain scan CT(NCCT) and CT pulmonary angiography (CTPA). Ctpa-like image effects can be simulated or reconstructed by non-enhanced plain scan CT images, so that CTPA-like image quality can be obtained without injecting contrast agent. The synthetic CTPA images were further analyzed by artificial intelligence to assist doctors in the intelligent diagnosis of pulmonary vascular diseases.

Detailed description: A non-enhanced plain scan CT image simulates or reconstructs an image effect similar to that of CTPA through the following technical solutions:

1. Data acquisition: Obtain plain scan CT image data of the examined person, including multiple layers of image slices.
2. Image preprocessing: Preprocessing of plain scan CT images, including denoising, enhancing contrast and other steps, to improve image quality and lay the foundation for subsequent processing.
3. Vascular segmentation: Advanced image segmentation algorithms, such as the deep learning-based segmentation method, are used to segment the vascular structure from the preprocessed plain scan CT images. The key to this step is to accurately identify and extract vascular areas while reducing interference from non-vascular tissue.
4. Blood vessel enhancement: For the segmented blood vessel structure, a specific image enhancement algorithm is used to enhance blood vessels to make them clearer and more continuous.
5. Image synthesis: The enhanced vascular image is fused with the original plain scan CT image to generate the final CTPA image. During the synthesis process, the contrast between blood vessels and surrounding tissues can be adjusted as needed to optimize the display effect.
6. Post-processing and evaluation: Post-processing of synthesized CTPA images, such as smoothing, artifact removal, etc., and quality assessment to ensure that the images meet the needs of clinical diagnosis.

Eligibility criteria: Inclusion Criteria:

* Age ≥18≤100 years old Scan the pulmonary artery and its major branches Patients with suspected pulmonary embolism who received CTPA had a set of CTPA and CT scans The image quality meets the requirements of diagnosis and post-processing Patients who completed the examination in accordance with the data collection criteria Clinical data and follow-up were complete

Exclusion Criteria:

* Age \&lt;18 years or age \&gt;100 years The image is incomplete or incorrect Pulmonary artery absent or underenhanced Severe motion artifacts or image noise affect evaluation of pulmonary embolism History of aortic reconstruction, replacement, or stent implantation Congenital variations in the whole or important branches of the aorta in adults (e.g. bovine aortic arch, abnormal right subclavian artery) Severe hypovolemia and hemodynamic instability Severe heart failure with low ejection fraction Dialysis patient

Primary outcomes:
measure: The performance of deep enhanced imaging in lesion detection and diagnosis
timeFrame: 2 year
Secondary outcomes:
Other outcomes:
Locations:
Study officials:
affiliation: Chinese PLA General Hospital
name: Xin Lou
role: STUDY_CHAIR
References: